BusinessArbutus Announces Conference Call to Provide a Corporate Update and Fourth Quarter 2017 Year-End Financial ResultsBy Nasdaq OMXMar 12, 2018, 1:00 PM UTC
BusinessCatalyst Pharmaceuticals Announces Date and Time Change for Fourth Quarter and Year-End Financial Results Call and WebcastBy Nasdaq OMXMar 12, 2018, 12:03 PM UTC
BusinessBioStem Technologies Inc. Enter into Agreement with Barbara Krutchkoff, PhD. To Guide Scientific AffairsBy Nasdaq OMXMar 9, 2018, 10:09 PM UTC
BusinessINSYS Therapeutics Reports Fourth Quarter and Full Year 2017 ResultsBy Nasdaq OMXMar 8, 2018, 9:16 PM UTC
BusinessSunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent HighlightsBy Nasdaq OMXMar 8, 2018, 9:06 PM UTC
BusinessCatalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results Conference Call and Webcast on Thursday, March 15th, 2018By Nasdaq OMXMar 8, 2018, 1:04 PM UTC
BusinessViaDerma, Inc. Provides an Update of Current Marketing ActivitiesBy Nasdaq OMXMar 8, 2018, 10:01 AM UTC
BusinessFibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized SclerodermaBy Nasdaq OMXMar 6, 2018, 1:02 PM UTC
